Clinical Trials Directory

Trials / Completed

CompletedNCT05892991

Using Different Amplitude-modulated Frequencies of IFC for the Treatment of Trigger Points

Influence of Using Different Amplitude Modulated Frequencies on the Effectiveness of Interferential Current in Treating Trapezius Trigger Points: a Randomized Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
132 (actual)
Sponsor
University of Hail · Academic / Other
Sex
All
Age
17 Years – 50 Years
Healthy volunteers
Not accepted

Summary

the authors of this work will conduct a randomized controlled trial intended to examine different amplitude-modulated frequencies of interferential current on different measures related to chronic trigger points located in the upper trapezius muscle.

Detailed description

this randomized controlled trial was designed to fill a gap in the literature regarding the most effective amplitude-modulated frequency of interferential current on pain pressure threshold, cervical ROM, and function of the neck region. this study will be consisted of 4 groups, all groups will receive standard manual treatment commonly used for the treatment of chronic trigger points. this treatment will be conducted 3 times per week for 4 weeks. The standard treatment will consist of an intermittent neuromuscular inhibition technique. the 3 experimental groups will receive interferential current sessions (3/week) for 4 weeks with the same parameters except for the amplitude-modulated frequency. outcome measurements will be assessed at baseline, at 4 weeks, and at 4 weeks of the end of the treatment (follow-up).

Conditions

Interventions

TypeNameDescription
OTHERinterferential currentthis intervention is a type of therapeutic electrical currents of medium frequency used commonly in physical therapy to relieve acute and chronic pain as well as stimulate muscle contraction.

Timeline

Start date
2023-10-01
Primary completion
2024-07-30
Completion
2024-08-01
First posted
2023-06-07
Last updated
2025-01-07

Locations

2 sites across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT05892991. Inclusion in this directory is not an endorsement.